Medicure Inc. (OTCMKTS:MCUJF – Get Free Report)’s stock price crossed below its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of $0.89 and traded as low as $0.69. Medicure shares last traded at $0.70, with a volume of 6,600 shares changing hands.
Medicure Trading Down 11.1 %
The company’s fifty day simple moving average is $0.78 and its two-hundred day simple moving average is $0.89. The company has a market capitalization of $7.34 million, a price-to-earnings ratio of -11.71 and a beta of 0.94. The company has a quick ratio of 1.55, a current ratio of 1.92 and a debt-to-equity ratio of 0.01.
Medicure (OTCMKTS:MCUJF – Get Free Report) last issued its quarterly earnings data on Monday, April 8th. The company reported ($0.10) EPS for the quarter. Medicure had a negative return on equity of 4.29% and a negative net margin of 4.17%. The business had revenue of $3.73 million for the quarter.
Medicure Company Profile
Medicure Inc, a biopharmaceutical company, engages in the research, development, and commercialization of human therapies for the cardiovascular market. The company markets and distributes AGGRASTAT injection, a glycoprotein GP IIb/IIIa receptor antagonist for the treatment of acute coronary syndrome, including unstable angina and non-Q-wave myocardial infarction.
Recommended Stories
- Five stocks we like better than Medicure
- Most Volatile Stocks, What Investors Need to Know
- TJX Companies Can Hit New Highs; Double-Digit Upside to Follow
- The 3 Best Blue-Chip Stocks to Buy Now
- A Hidden Gem Retailer With 20% Upside
- High Dividend REITs: Are They an Ideal Way to Diversify?
- Zoom Stock’s Earnings Volatility Picked Up a Lot of Buyers
Receive News & Ratings for Medicure Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medicure and related companies with MarketBeat.com's FREE daily email newsletter.